• Diversified product lines, new sales channels and distributors, an expanded sales team, and increasing social awareness of VPR Brands has increased profit margins
• GoldLine CBD product division increases target market and potential customers in the consumable supplements and nutraceuticals sectors
• Cutting-edge technology and user-centric designs uniquely engineered to be used with cannabis or CBD oils, concentrates and flowers
• Private label (white label) business is a growth sector; in 2018 VPR Brands white labeled several award-winning vaporizers for prominent companies
• Required testing and certification to allow all VPR Brand products to be imported and sold in the European Union is underway
• International sales efforts are ongoing and supported by a company representative who attends trade fairs and works to build relationships with distributors in each territory

Florida-based VPR Brands, LP (OTC: VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands’ current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company’s current product portfolio is comprised of the following:

• GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit CBDGoldLine.com.
• HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit VapeHoneyStick.com.
• Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium’s chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
• Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
• Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client’s purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
• GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit GoldLineHemp.com for more information about GoldLine Hemp-only products.
• Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor’s degree from the University of Miami School of Business.

For more information, visit the company’s website at www.VPRBrands.com

• Company is still leading the way in providing financial information for Chinese-speaking investors after 20 years
• CIIX aims to capitalize on the growing demand for CBD-based nutrition and health products in the U.S.
• ChineseHempOil.com has been rebranded and established as a one-stop online shop created for customer convenience

With 20 years of tested experience, ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in both the United States and China. The company has a highly diversified revenue stream and is working to further establish itself as a recognized leader in the hemp-based cannabidiol (CBD) oil industry. CIIX is laying groundwork to capitalize on the U.S. demand for CBD-based nutrition and health products.

As a leader in financial information, CIIX offers a variety of investor education products and services through its primary website, www.ChineseInvestors.com. The company leverages a unique combination of a disciplined investing process, web-based tools, personalized instructions and support to help investors make informed decisions aimed at meeting their personal goals.

CIIX’s management team has a keen ability to identify and act on value-enhancing opportunities. With two decades of tested experience as a financial information leader, CIIX is taking that same strength and applying it to the company’s online and retail distribution businesses.

Now that CBD is legal in all 50 U.S. states and can be exported to 40 countries, the U.S. cannabis industry is seeing an increase in demand, and CIIX is laying the groundwork to capitalize on the opportunity. The company is currently developing the first-ever marijuana social media mobile app. This Yelp-style app aims to provide the Chinese-speaking community with a platform to review and discuss various cannabis products and create consumer-based accountability within the industry.

The company is doing more than providing a platform for discussion around products. CIIX is also creating quality products for the cannabis industry. ChineseHempOil.com Inc. was recently rebranded. Now called opt, the site markets a wider variety of CBD-infused products to the U.S. market. Part of the rebranding included the consolidation of retail e-commerce sites into a single platform. The new website, www.365CWC.com, now offers three lines:

• The opt Hemp line includes gummies, oils, soft gels, cosmetics and other hemp-derived CBD products that are currently in development;
• The opt2mist line features spray-vitamin products that includes a wide array of daily vitamin sprays and full-spectrum, CBD-infused sprays; and
• NuLeaf Naturals products are formulated with high-grade, organic, full-spectrum hemp oil sourced from Colorado and free of pesticides, herbicides and chemical fertilizers.

In a news release (http://ibn.fm/j8DEk), CIIX CEO Warren Wang stated, “The consolidation of our domestic consumer sites into a single channel will provide a one-stop shop for busy consumers, which, in turn, we believe will ultimately drive sales.” The company expects this strategic step to help it build brand recognition as CIIX continues to roll out new products throughout 2019 and beyond.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• SOL is executing a 2019 acquisition and strategic partnership program to expand its legal cannabis market presence
• The company acquired all operations and assets of 3 Boys Farm, a brand known for its cultivation facilities and dispensaries; as part of this strategic expansion, 3 Boys will be opening eight new dispensaries in Florida over the course of 2019
• SOL’s subsidiary, Heavenly Rx, recently announced the acquisition of 568 acres of hemp farms for biomass production
• The company is also focusing on its international expansion, especially on the European market; plans are in motion to open a network of clinics for medical cannabis users throughout the UK

SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF), a leading international cannabis investment company, has been working on the establishment of its global legal cannabis market position through acquisitions and strategic partnerships. Since the beginning of 2019, SOL Global Investments has announced the completion of several new milestones in line with this strategic approach.

Most recently, the company announced that it received approval from the Florida Department of Health for the sale and transfer of the 3 Boys Farm license from CannCure Investment Inc. to SOL Global. All operations and assets will be transferred under the terms of the agreement. These assets include farms and dispensaries currently owned by the privately-held, Ontario-based CannCure corporation (http://ibn.fm/U6TJZ).

In addition, 3 Boys intends to open the first two dispensaries operating under the brand in Florida. The launch is anticipated in April 2019. There are plans for the opening of six additional dispensaries in prime medical and retail corridors throughout Florida by the end of the year.

SOL also announced that 3 Boys will begin extraction and processing operations at its new GMP farm and lab facility in Indiantown, Florida. The facility became operational in the last week of March, and cultivation is anticipated to commence in the fourth quarter of 2019.

The acquisition of the 3 Boys Farm license isn’t the only development in line with the company’s strategic expansion policy. On March 7, 2019, SOL Global announced that its subsidiary, Heavenly Rx, will be acquiring 568 acres of hemp farms for biomass production (http://ibn.fm/18MsV).

Heavenly Rx, a hemp-focused SOL subsidiary, was formed in February 2019. The subsidiary’s initial goal was hemp cultivation, but it also has interest in various hemp/CBD and THC-free cannabinoid wellness industry assets. Apart from cultivation, Heavenly Rx will specialize in the development of various CBD offerings, such as oils, balms, tinctures and vape-ready products.

As part of the latest agreement, Heavenly Rx will acquire 420 acres of agricultural property in McMinn County, Tennessee. The other 148 acres of agricultural property are located in Whitley County, Kentucky. The locations were chosen for their temperate climate and ideal environmental conditions for greenhouse and outdoor growing.

Through the acquisition, Heavenly Rx will expand its capability to fulfill national and international orders in the future. The aim is for Heavenly Rx to become a vertically-integrated leader in the hemp and CBD marketplaces.

Under the terms of the acquisition, Heavenly Rx will also benefit from favorable contract farming rates in Tennessee and Kentucky. During the first year of contract farming, the yield is anticipated to reach 50,000 pounds of hemp biomass.

“We’re excited to partner with some of the best hemp farmers in the United States on this latest venture, which strengthens our vertically integrated hemp and CBD international rollout plan,” SOL Global CEO Brady Cobb said in a news release. “This acquisition will allow Heavenly Rx to expand its leadership role in the U.S. hemp and CBD industry, and Blühen Botanicals’ industry-leading expertise in hemp processing and extraction will prove a valuable asset in the management and cultivation of the properties.”

Blühen Botanicals is a Heavenly Rx portfolio company that specializes in hemp biomass processing and extraction. The company has farming and distribution partners across the U.S., and it also possesses a dedicated pharmaceutical-grade hemp research facility.

Expansion across the U.S., however, isn’t SOL’s only strategic goal. As previously mentioned, the company will be striving to expand its international presence through acquisitions and strategic partnerships.

At the beginning of March 2019, SOL announced a groundbreaking achievement made by its European Cannabis Holdings (“ECH”). In February 2019, ECH became the first company in the UK to facilitate the importation of a bulk shipment of medical cannabis (http://ibn.fm/NOz1A).

ECH will also be opening a network of medical cannabis clinics in the UK. As per the official announcement, the clinics will become operational in the spring of 2019, and they will be located in numerous big cities across the UK. The clinics are expected to focus on the treatment of chronic and debilitating conditions like neurological disorders, chronic pain and psychiatric problems. The company notes that patients who have exhausted other treatment options could benefit profoundly from the alternative possibilities available at the ECH clinics.

The medical cannabis clinic announcement came in the aftermath of an official UK Home Office decision to reschedule medical cannabis. Regardless of legislative changes, access to such treatments has been limited. The new ECH clinics will provide readily available opportunities to patients in desperate need of reliable and effective treatment options.

All of the clinics will focus on innovative cannabis-based treatment options. Such treatments will be available to patients following a health care professional’s referral.

“ECH has proven time and again to be a leader in the European cannabis market. As the UK medical cannabis market continues to open up, ECH’s cohesive network of companies will be instrumental in providing patients with much needed access to the potential therapeutic treatments offered by CBD and cannabis. We’re confident that ECH offers our Shareholders the best opportunity available to access the growth of the European market through investment,” Cobb added.

SOL Global continues to work toward the identification of key partners and markets in both the U.S. and international cannabis industries.

Legalization changes in numerous parts of the world, genetic development and intellectual property advancements in the cannabis sector have already contributed to the growth of the market and are expected to continue doing so in the future. The global legal cannabis market is anticipated to grow at a CAGR of more than 27 percent through 2023 (http://ibn.fm/nBn5r), while global spending is forecast to increase, from $20.1 billion in 2018 to over $63 billion in 2024 (http://ibn.fm/43Pk3).

For more information, visit the company’s website at www.SOLGlobal.com

• Cannabis Strategic Ventures sustains entrepreneurial growth within California’s cannabis industry through a diverse portfolio
• The company is building cultivation ventures in both Southern California and Northern California, and it recently received a $3 million funding commitment
• NUGS has filed an application to uplist to the OTCQB Venture Market this year
• California is a leader in the global cannabis oil market, which is expected to reach about $2.46 billion in sales by 2025

As California tax and fee regulators celebrate the approximately $300 million in sales and excise tax receipts brought in during the first year of recreational marijuana legalization in the state, Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) is honing its focus on supporting entrepreneurial growth within the fast-expanding industry through active buy-in by the company’s varied subsidiaries.

Analysts at Arcview Market Research and BDS Analytics predict that the legalization of adult-use recreational sales in California will lead to the creation of close to 99,000 cannabis industry jobs between 2018 and 2021 – 146,000 jobs overall, when ancillary industries are considered (http://ibn.fm/0Q7Pb). Cannabis Strategic Ventures’ Budhire subsidiary is equipped to play a key part in the growth of the industry by utilizing its proven recruitment strategy to match top employment candidates to a broad spectrum of cannabis industry jobs. The company also provides sector-specific outsourced professional employment and human resources consulting services.

The company’s Pure Applied Sciences subsidiary produces its PureOrganix brand as a line of high-quality, concentrated, organic and pure cannabis oils that meet current Good Manufacturing Practices (cGMP) standards and FDA guidelines. A March 18 report by The Street states that a rich universe of options continues to scale up around oils and edibles as people look for cannabis use options that don’t include burning the plant (http://ibn.fm/uqQEQ).

A report by Zion Market Research predicts that the global cannabis oil market will reach approximately $2.46 billion by 2025, growing at a CAGR of around 49.5 percent from 2018’s $147-million level (http://ibn.fm/4VK7z).

Thus far in 2019, NUGS has filed an application for uplisting to the OTCQB Venture Market; announced that it will partner with a Santa Barbara County cultivation operation that holds about 40 commercial cannabis licenses in Southern California; revealed that it will add a six-acre Northern California site to its holdings after having obtained over 20 licenses for cannabis manufacturing, distribution and cultivation there; and secured an investment of up to $3 million from student-led business Triton Funds subsequent to an upcoming S1 registration statement, which will allow Cannabis Strategic Ventures to accelerate its cultivation business priorities and the expansion of its existing portfolio brands.

“California is instrumental in setting the pace for the larger cannabis industry — both nationally and globally, and we are thrilled to have found a local partner to escalate the projects that we believe will positively impact stakeholder value to create superior, sustainable returns,” Cannabis Strategic Ventures CEO Simon Yu stated in a news release (http://ibn.fm/tz6Sj).

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• LXRP CEO Chris Bunka explained in the interview that proprietary technology can save 60,000 lives annually if consumption habits of even one percent of smokers worldwide change
• CEO Clips videos are featured on business sites including BNN Bloomberg, Thomson Reuters, Yahoo! Finance and Stockhouse.com
• Bunka went on to described LXRP’s growing patent portfolio and noted that ingesting rather than inhaling, using DehydraTECH technology, could be a lifesaver

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka sought to raise awareness of LXRP in the financial community as he appeared, March 23­­-24, on CEO Clips via YouTube. In the video, Bunka explained the benefits of DehydraTECH technology, noting that ingesting drugs and molecules is healthier than inhaling them, and doing so could be a lifesaver for smokers around the world.

CEO Clips boasts the largest library of publicly traded CEO videos broadcast in the United States and Canada on national TV and on 15 business sites, such as BNN Bloomberg, Yahoo! Finance, Thomson Reuters, Stockhouse.com and others.

“Lexaria Bioscience has the actual opportunity of changing the world,” Bunka said in the video (http://ibn.fm/keHWB). “We can do it through saving lives, making health improvements for any number of people who are injecting any number of drugs or molecules like pain relief, cannabinoids or nicotine. Everybody knows that smoking is not healthy. Our technology allows for the delivery of drug molecules like cannabinoids or nicotine through ingestible means, things that you swallow. It could be a pill, a syrup or a cup of coffee. That technology, which is called DehydraTECH, is optimized to carry that drug across the intestinal wall and get more of it to your bloodstream more quickly than it otherwise could.”

He added that LXRP has tested DehydraTECH in vitro and in vivo in human clinical studies. Bunka further explained, “We actually have seven different R&D projects that we are launching in the first half of 2019. We’re also continuing to work on our patent portfolio. We have ten patents granted already and over 50 more that are pending. If we are able to help change the consumption habits of even one percent of the global marketplace who smoke we could save 60,000 lives a year.”

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator, and DehydraTECH is the company’s proprietary absorption technology platform. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio that includes 10 patents granted in the United States and Australia, and more than 50 patent applications worldwide across 10 patent families.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Job growth in cannabis industry rose 44 percent in 2018, outpacing other sectors in job market
• Subsidiary BudHire uniquely positioned to capitalize on growing need for outsourced personnel solutions
• Legal cannabis spending worldwide expected to increase from $20.1 billion in 2018 to $43.3 billion in 2022 and $63.5 billion in 2024

Cannabis Strategic Ventures Inc. (OTC: NUGS), a Los Angeles-based cannabis firm, is moving swiftly to secure footholds in various sectors of the booming cannabis industry. Economists note that job creation in the cannabis industry is beginning to roll out massive numbers on both the recreational and medicinal sides, with 64,389 new positions added in 2018. That’s a 44 percent increase on the previous year, making it the fastest-growing job sector in the country right now, as an article in Forbes points out (http://ibn.fm/ImSyx).

Supporting this rapidly growing industry is the prime strategy of Cannabis Strategic Ventures. Among the company’s subsidiaries is the aptly-named BudHire, an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations. Research conducted by Glassdoor shows that cannabis job openings are increasing rapidly, with 1,512 open in the U.S. during December 2018 – a 76 percent increase over the same period in the previous year. More than 50 percent of those jobs are for professional and technical workers from a variety of fields, Glassdoor found (http://ibn.fm/BsmkE).

Cannabis Strategic Ventures and BudHire utilize a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire brand, Cannabis Strategic Ventures offers temporary, seasonal and permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry (http://ibn.fm/3mqL3).

The legal status of cannabis continues to evolve, with several legislative bodies in numerous U.S. states taking up the issue. In recent days, legislators in New Jersey shelved a bill that would legalize adult-use cannabis, while a legislative law committee in Connecticut approved a plan that would establish a framework for the sale of cannabis products (http://ibn.fm/qAFHS). Legislators in New York are still discussing the issue. So far, 10 U.S. states have now legalized the recreational use of cannabis, while another 34 have approved its use for medicinal purposes.

For Cannabis Strategic Ventures, staying ahead of the curve includes cultivating and partnering with category leaders in the cannabis and CBD (cannabidiol) markets. The company’s portfolio of subsidiaries also includes:

• The Asher House Wellness, a producer of high-quality ingestible CBD oil products tailored for pet consumption;
• Fitamins, a producer of sports performance products derived from phytocannabinoids, hyaluronic acid and MSM;
• LYXR, a line of luxury skin care products derived from hemp CBD and other dynamic ingredients with hydrating, regenerating and anti-aging properties;
• Halo Filters, a developer of industry-leading filters made of patent-pending materials that reduce harmful chemicals and protects the lungs; and
• Pure Applied Sciences Inc., whose offerings under the Pure Organix brand include a line of high-quality, organic, cGMP- and FDA-compliant cannabis oils.

Recently, Cannabis Strategic Ventures announced that it has secured a $3 million investment to fast-track corporate expansion. The company obtained this investment from Triton Funds subsequent to a forthcoming S1 registration statement (http://ibn.fm/73h9c). This financing is expected to enable Cannabis Strategic Ventures to hasten its business priorities associated with cannabis cultivation operations in California and the expansion of existing portfolio brands.

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• The company estimated unaudited revenue of $8.4 million for the fiscal period ended December 31, 2018
• The figure represents a 684 percent increase over FY2017 revenues
• Plus Products was ranked as the number one edibles brand in California during the third quarter of 2018

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading edibles manufacturer with sales exclusively in California, recently provided its unaudited revenue estimate for the fiscal period ended December 31, 2018. This revenue estimate indicates that the company witnessed impressive growth during the 12-month period (http://ibn.fm/w7DZc).

The company estimates that its unaudited revenue for the period totaled $8.4 million. This figure represents a 684 percent increase over its FY2017 revenues of $1.1 million (http://ibn.fm/funFW). Fourth-quarter revenue estimates for 2018 were $3.4 million, marking a nearly 32 percent increase over the third quarter of 2018. In addition, the company’s retail sales in the fourth quarter were $10.53 million – nearly 40 percent more than the third quarter of 2018.

Most significantly, Plus Products was ranked as the top edibles brand in California during the third quarter of 2018, according to retail sales data gathered by both BDS Analytics and Headset (http://ibn.fm/aYRVT).

The company seeks to support consumers in pursuing a healthy and active lifestyle by providing premium-quality edibles products. Indeed, according to BDS Analytics, PLUS Uplift and PLUS Restore retained their positions as the top two best-selling edibles products in California.

The company’s PLUS Uplift Sour Watermelon gummy secured (http://ibn.fm/9koi7) the industry’s position as the “top selling branded product of the more than 20,000 products sold across all cannabis categories in California in 2018.” Similarly, the company’s PLUS Blackberry & Lemon Gummy was the second-best-selling branded product across all categories in California. This included flower, vaporizers, edibles and topicals (http://ibn.fm/aiPHy).

This steady revenue growth and noteworthy product acclaim are made all the more remarkable for Plus Products when accounting for California’s recent market trends. In 2018, there were 17 percent less legal sales in California cannabis than in 2017. Though the California cannabis market was often impeded by “licensing challenges, regulatory changes, taxes and new testing, and labelling and packaging requirements,” PLUS maintained its steady growth. Due to its increase in unit sales, PLUS has improved its edibles market position from number four to number one in retail value of sales (http://ibn.fm/vyWLJ).

In a news release (http://ibn.fm/YzzzI), Plus Products CEO Jake Heimark said, “We are grateful to the California consumers who have made PLUS the leading cannabis product in California, the largest and most competitive cannabis product in the world.” He noted that the company is intent on broadening its geographic reach while pledging to consistently offer its customers products that deliver “consistent experiences in delicious formats.”

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Wildflower Brands is advancing its goal of becoming a global health and wellness leader by inking a delivery fulfillment agreement with nationally prominent cannabis educator HelloMD
• Wildflower has been investing in building its cannabis licenses, products and services in California, as well as in online outlets and throughout the United States
• The company’s online store sales have grown more than 300 percent since January 2018, with yearly revenues topping $1 million

Plant-based health and wellness brand builder Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) recently announced a delivery fulfillment agreement with medical cannabis education outlet HelloMD, expanding the monetization of Wildflower’s California operations.

WLDFF’s brands, Wildflower Wellness, King Extracts and Exclusive, are the vehicles by which the company is working to become a global wellness leader. Wildflower Wellness is focused on delivering its lineup of full-spectrum cannabidiol (CBD)-infused products through the media of CBD vaporizers, capsules, tinctures and soaps. King Extracts focuses on delivery systems that comply with California’s regulations and on related technologies, including concentrates made from CO2 extractions with proprietary terpenes blended in for flavor. Exclusive dispenses high-quality cannabis in Los Angeles, working closely with select hospital oncology departments and community programs.

The delivery agreement with HelloMD establishes a working partnership with a prominent national platform for cannabis doctors, consumers and brands. Through joint ventures or white-label solutions, HelloMD partners leverage its platform to attract, nurture, convert and retain patient demand for medical cannabis.

“HelloMD has been a significant wholesale customer and provides us with a great position as a premium health and wellness brand,” Wildflower CEO William MacLean stated in a news release about the agreement (http://ibn.fm/vGXgD). “I am very happy to see our relationship grow to further bring quality information and products to consumers with conditions that benefit from plant-based healing in a timely manner.”

California is the world’s largest cannabis market, although Canada is expected to eventually overtake the state during the next decade thanks to its nationwide drive toward full legalization of cannabis use (http://ibn.fm/AEKuF).

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail, but the company’s distribution network extends beyond California to more than 200 retailers in the state of Washington and more than 20 additional retailers in New York City. Between the two coasts, distribution in other U.S. markets includes over 80 wellness and health care practitioners that boost Wildflower’s total distribution to over 300 stores nationwide.

The company reports that its direct-to-consumer online store sales have seen growth of more than 300 percent since January 2018, with yearly revenues topping $1 million. Revenues have increased for nine reporting quarters without a break in the trend.

WLDFF recently completed a private placement of $1.8 million to fund the build out of the company’s manufacturing capability in Washington in response to the growing demand for its products, as well as for general working capital to further Wildflower’s interests.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• Kontrol Energy and Toyota Tsusho Canada recently announced a strategic partnership that will result in a smart factory tech solution based on Kontrol’s IoT hardware and software
• In addition, Kontrol announced plans to be offer innovative solutions in the cannabis industry for odor and emission control

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8), a smart energy technology company, is planning to expand its smart solutions and introduce new developments in various verticals during 2019. At the end of March 2019, the company announced a strategic partnership, followed by an early April announcement that it plans to expand its odor and emission solutions for the cannabis industry.

Kontrol Energy and Toyota Tsusho Canada announced a smart factory strategic partnership on March 25, 2019 (http://ibn.fm/jz1TM). The smart factory tech solution will bring together Kontrol’s internet of things (IoT) hardware and software with Toyota Tsusho Canada’s existing production. The aim of the partnership is to ensure the operation of improvement platforms and power generation/HVAC products for the North American automobile and OEM parts industries.

“We selected Kontrol as our partner in the Smart Factory initiatives due to their extensive experience in developing technology solutions which integrate IoT hardware and software to create a smart environment to optimize operating efficiencies. This agreement with Kontrol will enable us to deliver production and energy efficiencies and give our customers a technology solution to drive down their costs and gain a competitive advantage,” Toyota Tsusho Canada President Hidetoshi Tada said in a news release.

On April 1, Kontrol made an additional announcement, this time targeting innovation in the cannabis industry (http://ibn.fm/tEpUM). The company announced an expansion of its solutions aimed at addressing increasing regulations from local and provincial governments pertaining to cannabis growing and production.

These regulations are meant to deal with emissions and odors in various industry sectors across Canada. As the cannabis industry became legalized, the need for odor control solutions increased. Ensuring compliance is something with which many businesses aren’t prepared to deal, Kontrol Energy CEO Paul Ghezzi said.

ORTECH, Kontrol’s operating subsidiary, has more than 40 years of experience in dealing with emissions and odors in various industries. The company offers turn-key services tailored to the needs of respective businesses and scientifically aimed at identifying, measuring and mitigating VOCs.

Through such developments, Kontrol will be positioned to expand its market share and establish a solid position in the growing Canadian legal cannabis market.

While 2019 is just getting started, the year has proven to be very fruitful for Kontrol so far. The company already secured its third contract with a licensed Ontario cultivator for emission and odor control.

Kontrol’s growth was further strengthened through a series of acquisitions. Since its inception, the company has finalized six acquisitions that include Kontrol Technologies, Log-One Ltd., ORTECH Consulting Inc., Efficiency Engineering Inc., MCW Dimax Ltd. and CEM Specialties Inc. A seventh possible acquisition was announced on March 14, 2019. Based on these milestones, Kontrol has accomplished amazing revenue growth, Ghezzi noted.

For more information, visit the company’s website at www.KontrolEnergy.com

NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company’s newsroom at http://ibn.fm/KNRLF

• Youngevity International is a multi-faceted lifestyle company that is rapidly increasing its hemp-based cannabidiol oil production for varied industries
• Youngevity subsidiary Khrysos Global has inked a contract to provide 50 percent of its capacity for 99 percent pure cannabidiol oil, with additional contracts anticipated
• Cannabidiol-infused beverages are gaining traction in the emerging cannabis industry, with anticipated revenue potential between $900 million and $4.4 billion by 2024
• Youngevity’s HempFX and CLR Roasters brands will begin selling cannabidiol-infused coffees next month, and the company is working on another cannabidiol drink under an agreement with Icelandic Glacial bottled water

Multi-faceted and flexibly-oriented lifestyle company Youngevity International Inc. (NASDAQ: YGYI) is expanding its operations in the cannabis industry following the announcement that its subsidiary, Khrysos Global, has entered a contract to produce 99 percent pure cannabidiol oil from hemp that’s free of the psychedelic tetrahydrocannabinol (THC) found in cannabis’ marijuana strains.

The one-year supply and processing agreement is expected to begin with shipments this month and continue in equal amounts through March 2020, amounting to what Khrysos President Dwayne Dundore described as 50 percent of the company’s production capacity utilizing its supercritical CO2 technology (http://ibn.fm/FH1l7). Contracts for the remainder of the company’s production capacity are expected to be executed during “the next few months,” he added.

“We are excited to reach the revenue stage for the end to end processing component of our business model,” Dundore stated in the news release. “Due to customer demand we are implementing our plan of increasing our end to end processing capabilities by 10 times in Q3 of this year providing estimated annual revenue potential in excess of $220 million at current market prices.”

Youngevity acquired Khrysos Global in February (http://ibn.fm/W9aFh). Khrysos is a Florida-based manufacturer of hemp-based CBD extraction equipment and the operator of INX Labs, which provides environmental analysis, fuel and feedstock analysis and mined rare earth analysis (http://ibn.fm/m9C1b).

The Khrysos acquisition accelerated YGYI’s activity in the hemp-based CBD industry, providing systems that could be immediately implemented in YGYI’s line of HempFX products and in offtake agreements that the company has through its existing business relationships, according to CEO and Chairman Steve Wallach.

“We see this as providing not only immense value to our company, but also to our investors since we’ll be selling not just the extraction systems, but also generating income servicing and operating these systems via a rental model,” Wallach added.

Youngevity’s virtual Main Street stable of products and services allows the direct marketer to appeal to consumers in the top eight revenued retail categories, including health and nutrition, home and family, food and beverage (including coffee), spa and beauty, fashion, essential oils, photo and innovative services. The company’s hybrid direct sales business model values e-commerce and social selling and is particularly serviceable to the cruise line industry.

In January, the company announced an exclusive agreement with Icelandic Glacial bottled water that’s anticipated to lead to the development of a ready-to-drink CBD product. In March, the company added plans to launch CBD-infused coffees, which are expected to begin with rollout under Youngevity’s HempFX brand early next month, followed by a second product under its CLR Roasters brand later in the month.

An estimated 64 percent of American adults drink coffee on a regular basis, according to a 2018 study commissioned by the National Coffee Association (NCA) (http://ibn.fm/IM8I2), and analysts at Deloitte foresee the potential revenues for the overarching cannabis-infused beverages market at somewhere between $900 million and $4.4 billion by 2024 (http://ibn.fm/dAA7x), highlighting the expanding potential for the company.

For more information, visit the company’s website at www.Youngevity.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI